Blueshift Asset Management, LLC Amarin Corp Plcuk Transaction History

Blueshift Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$2.85 - $3.73 $32,900 - $43,059	-11,544 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$3.24 - $5.18 $37,402 - $59,797	11,544 New	11,544 $39,000
Q3 2020 Nov 13, 2020	SELL	$3.64 - $7.76 $49,991 - $106,575	-13,734 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$4.78 - $8.26 $65,648 - $113,442	13,734 New	13,734 $95,000
Q4 2019 Feb 14, 2020	SELL	$13.94 - $24.12 $488,164 - $844,658	-35,019 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$13.89 - $23.16 $486,413 - $811,040	35,019 New	35,019 $531,000

181

69.6M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $210M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Blueshift Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Blueshift Asset Management, LLC with notifications on news.